GLP-1

GLP-1 is tracked across RERIGHT’s news graph. Explore its connections and the latest headlines below.

Latest on GLP-1

• Opinion: Burdensome Medicare GLP-1 program may keep patients from accessing $50 per month weight loss drugs
• How Ozempic maker Novo Nordisk blew its lead in GLP-1 weight-loss drugs. Can Europe compete in the high-stakes global economy?
• Lilly’s revenue soars 48%, driven by demand for its GLP-1s
• A father’s mission to save his daughter, and allegations on telehealth GLP-1 prescribing
• STAT+: Novo Nordisk sues Eli Lilly over GLP-1 drug ads it calls ‘deceptive’
• Novo Nordisk sues Eli Lilly over ads as GLP-1 market hits ‘inflection point’

Connections

8 entities linked to GLP-1 across the news graph.